Role of adrenergic receptors in human coronary vasomotion ...



Role of adrenergic receptors in human coronary vasomotion (ht150888)

Emanuele Barbato

Web only references

1. Chilian WM. Functional distribution of α1- and α2-adrenergic receptors in the coronary microcirculation. Circulation 1991;84:2108 –2122

2. Heusch G, Deussen A, Schipke J, et al. α1- and α2-adrenoceptor mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol 1984;6:961–968

3. Angus JA, Cocks TM, Satoh K. The alpha adrenoceptors on endothelial cells. Fed Proc 1986;45:2355-2539

4. Muntz KH, Olson EG, Lariviere GR, et al. Autoradiographic characterization of beta adrenergic receptors in coronary blood vessels and myocytes in normal and ischemic myocardium of the canine heart. J Clin Invest 1984;73:349-357

5. Vatner SF, Hintze TH, Macho P. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog. Circ Res 1982;51(1):56-66

6. Ferro A, Kaumann AJ, Brown MJ. Beta-adrenoceptor subtypes in human coronary artery: desensitization of beta2-adrenergic vasorelaxation by chronic beta1-adrenergic stimulation in vitro. J Cardiovasc Pharmacol 1995;25(1):134-41

7. Ghaleh B, Béa ML, Dubois-Randé JL, et al. Endothelial modulation of beta-adrenergic dilation of large coronary arteries in conscious dogs. Circulation 1995;92(9):2627-35

8. Heyndrickx GR, Muylaert P, Pannier JL. (-adrenergic control of oxygen delivery to myocardium during exercise in conscious dogs. Am J Physiol 1982;242:H805-H809

9. Heyndrickx GR, Vilaine JP, Moerman EJ, et al. Role of prejunctional (2-adrenergic receptors in the regulation of myocardial performance during exercise in conscious dogs. Circ Res 1984;54:683-693

10. Adam KR, Boyles S, Scholfield PC. Cardio-selective (-adrenoceptor blockade and the coronary circulation. Br J Pharmacol 1970;40:534-536

11. Mark AL, Abboud FM, Schmid PG, et al. Differences in direct effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels. J Clin Invest 1972;51:279-287

12. Gross GJ, Feigl EO. Analysis of coronary vascular beta receptors in situ. Am J Physiol 1975;228:1909-1913

13. Duncker DJ, Stubenitsky R, Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward β-adrenergic control. Circ Res 1998;82:1312–1322

14. Lorenzoni R, Rosen SD, Camici PG. Effect of (1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans. Am J Physiol. 1996;40:H1302–H1306

15. Kern MJ, Ganz P, Horowitz JD, et al. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation 1983;67:1178-1185

16. Böttcher M, Czernin J, Sun K, et al. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 1997;38(3):442-6

17. Aptecar E, Dupouy P, Benvenuti C, et al. Sympathetic stimulation overrides flow-mediated endothelium-dependent epicardial coronary vasodilation in transplant patients. Circulation 1996;94:2542–2550

18. Dubois-Rande J-L, Dupouy P, Aptecar E, et al. Comparison of the effects of exercise and cold pressor test on the vasomotor response of normal and atherosclerotic coronary arteries and their relation to the flow-mediated mechanism. Am J Cardiol 1996;76:467– 473.

19. Mudge GH, Goldberg S, Gunther S, et al. Comparison of metabolic and vasoconstrictor stimuli on coronary vascular resistance in man. Circulation. 1979;59:544 –550

20. Nabel EG, Ganz P, Gordon JB, et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988;77:43–52

21. Zeiher AM, Drexler H, Wollschlager H, et al. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391–401

22. Dakak N, Quyyumi AA, Eisenhofer G, et al. Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol 1995;76:125–130

23. Yeung AC, Vekshtein VI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;325:1551–1556

24. Seiler C, Hess OM, Buechi M, et al. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993;88:2139–2148

25. Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094 –1100

26. Nabel EG, Selwyn AP, Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation 1990;81:850–9

27. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986;73:662–7

28. Kern MJ, Horowitz JD, Ganz P, et al. Attenuation of coronary vascular resistance by selective alpha1-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol 1985;5:840–6

29. Vita JA, Treasure CB, Yeung AC, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992;85:1390–7

30. Gregorini L, Marco J, Bernies M, et al. The alpha-1 adrenergic blocking agent urapidil counteracts postrotational atherectomy “elastic recoil” where nitrates have failed. Am J Cardiol 1997;79:1100 –1103

31. Gregorini L, Marco J, Palombo C, et al. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents. J Am Coll Cardiol 1998;31:992–1001

32. Gregorini L, Marco J, Kozakova M, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999;99:482– 490

33. Indolfi C, Piscione F, Ceravolo R, et al. Limb vasoconstriction after successful angioplasty of the left anterior descending coronary artery. Circulation. 1995;92:2109 –2112

34. Barbato E, Bartunek J, Aarnoudse W, et al. Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenosis. Eur Heart J 2004;25:2034–39

35. Aarnoudse W, Geven M, Barbato E, et al. Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease. Am J Cardiol 2005;96:1627–1630

36. Neill WA, Nakornchai V, Oxendine J, et al. Effect of beta-adrenergic suppression by propranolol on coronary collateral development in response to chronic coronary ischemia in dogs. Circulation 1979;59;280-285

37. Maruoka Y, McKirnan MD, Engler RL, et al. Functional significance of alpha-adrenergic receptors in mature coronary collateral circulation of dogs. Am J Physiol 1987;253(3 Pt 2):H582-90

38. Traverse JH, Altman JD, Kinn J, et al. Effect of (-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise. Circulation 1995;91:1560-1567

39. Sofowora GG, Dishy V, Landau R, et al. Alpha 1A-adrenergic receptor polymorphism and vascular response. Clin Pharmacol Ther 2004;75(6):539-45

40. King D, Etzel JP, Chopra S, et al. Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotype. Clin Pharmacol Ther 2005;77(5):388-403

41. Muszkat M, Sofowora GG, Xie HG, et al. Alpha2B adrenergic receptor 301-303 deletion polymorphism and vascular alpha2 adrenergic receptor response. Pharmacogenet Genomics 2005;15(1):23-8

42. Brodde O-E, Leineweber K. β2-Adrenoceptor gene polymorphisms. Pharmacogenet Genomics. 2005;15:267–275

43. Gratze G, Fortin J, Labugger R, et al. Beta-2 adrenergic receptor variants affect resting blood pessure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999;33:1425–1430

44. Hoit BD, Suresh DP, Craft L, et al. Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000;139:537-542

45. Snapir A, Koskenvuo J, Toikka J, et al. Effects of common polymorphisms in the α1A-, α2B-, β1- and β2-adrenoreceptors on haemodynamic responses to adrenaline. Clin Sci 2003;104:509–520

46. Cockroft JR, Gazis AG, Cross DJ, et al. β2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000;36:371–375

47. Garovic VD, Joyner MJ, Dietz NM, et al. β2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 2003;546:583–589

48. Bruck H, Leineweber K, Park J, et al. Human β2-adrenergic receptor gene haplotypes and venodilation in vivo. Clin Pharmacol Ther 2005;78:232–238

49. Khalaila JM, Elami A, Caraco Y. Interaction between beta2 adrenergic receptor polymorphisms determines the extent of isoproterenol-induced vasodilatation ex vivo. Pharmacogenet Genomics 2007 Oct;17(10):803-11

50. Dishy V, Landau R, Sofowora GG, et al. Beta2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo. Pharmacogenetics 2004;14(8):517-22

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download